Bio-Reference Laboratories Inc (NASDAQ:BRLI)

35.40
Delayed Data
As of 3:57pm ET
 +0.4599 / +1.32%
Today’s Change
24.19
Today|||52-Week Range
35.57
+10.18%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$969.6M

Company Description

Bio-Reference Laboratories, Inc. provides clinical laboratory testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. It offers a comprehensive list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology, services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology and other tissue analysis. The company primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. It also offers laboratory services to physician offices in the areas with an infrastructure that includes a comprehensive logistical department, extensive phlebotomy services and phlebotomy draw stations scattered around its geographic area. Bio-Reference Laboratories was founded by Marc D. Grodman on December 24, 1981 and is headquartered in Elmwood Park, NJ.

Contact Information

Bio-Reference Laboratories, Inc.
481 Edward H. Ross Drive
Elmwood Park New Jersey 07407
P:(201) 791-2600
Investor Relations:

Employees

Shareholders

Other institutional51.36%
Mutual fund holders32.57%
Individual stakeholders15.22%

Top Executives

Marc D. GrodmanChairman, President & Chief Executive Officer
Howard DubinettChief Operating Officer, Director & Executive VP
Sam SingerCFO, Director, CAO & Senior Vice President
Richard L. FahertyChief Information Officer
James WeisbergerChief Medical Officer, SVP & Laboratory Director

To view my watchlist

Not a member yet?

Sign up now for a free account